6505--NEW IDIQ - NON Cyclotron Radiopharmaceuticals For time period covering FY 2025 through FY 2030
ID: 36C26125Q0261Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF261-NETWORK CONTRACT OFFICE 21 (36C261)MATHER, CA, 95655, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/a3643416727640c8b79e210fdc69bdf9/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to provide NON-Positron Emission Tomography (PET) Radiopharmaceuticals through a new Indefinite Delivery Indefinite Quantity (IDIQ) contract for the period covering Fiscal Years 2025 through 2030. The procurement aims to secure reliable and compliant supplies of prepared single doses of radiopharmaceuticals, adhering to strict quality and regulatory standards, with an emphasis on promoting small business participation in federal procurement. These radiopharmaceuticals are critical for supporting the healthcare services provided by the VA, ensuring timely delivery and compliance with safety regulations. Interested parties should contact Contract Specialist Edward Hunter at edward.hunter@va.gov for further details regarding the solicitation and requirements.

    Point(s) of Contact
    Edward HunterContract Specialist
    edward.hunter@va.gov
    Files
    Title
    Posted
    36C26125Q0261_1.docx
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quote (RFQ) for non-Positron Emission Tomography (PET) radiopharmaceuticals intended for the Palo Alto Healthcare System, covering fiscal years 2025 to 2030. The presolicitation notice indicates that the RFQ is classified under the Product Service Code 6505 and the NAICS code 325412. Potential vendors must respond to the solicitation by February 26, 2025, with solicitation documents expected to be available around February 12, 2025. The VA plans to award a single firm-fixed-price contract for the procurement. Interested parties are instructed to direct any inquiries regarding the solicitation to the contracting officer, Edward Hunter. Overall, this initiative underscores the VA's commitment to sourcing necessary medical supplies to maintain healthcare services for veterans while adhering to government procurement protocols.
    36C26125Q0261.docx
    The document outlines a Request for Quote (RFQ) from the Department of Veterans Affairs for NON-Positron Emission Tomography (PET) Radiopharmaceuticals for the Palo Alto Healthcare System. It details the requisition and contract numbers, effective dates, and the requirements for bidders, emphasizing a set-aside for small businesses. The contractor is expected to provide prepared single doses of radiopharmaceuticals, follow strict quality and regulatory standards, and ensure timely delivery in accordance with specified guidelines. The contract spans a performance period from FY 2025 to FY 2030, with options for extensions. Specific mandatory tasks include licensing, labeling, compliance with safety regulations, and quality control. The contractor must accept returns under defined conditions. The RFQ includes subsections outlining contract terms, administrative procedures, and additional contractual clauses, emphasizing adherence to federal standards. Ultimately, the objective of the RFQ is to secure reliable and compliant supplies of radiopharmaceuticals to support the VA's healthcare service provision while promoting small business participation in federal procurement.
    Attachement 1 - Price-Cost Schedule for Usage.xlsx
    The FY25 Price-Cost Schedule outlines a federal government request for proposals regarding the procurement of various radiopharmaceuticals and radionuclides, totaling approximately $2.26 million over five years. It specifies estimated quantities and pricing for a variety of isotopes, including Tl-201 Chloride, Ga-67, and I-123 capsules, categorized by unit of measure such as mCi (millicuries) and uCi (microcuries). Key items include Tc99m products for pulmonary and perfusion imaging, with individual unit costs and quantities detailed throughout. The document emphasizes the need for 100% Low-Enriched Uranium (LEU) materials and includes potential fees for after-hours service, pharmacist calls, and cancellation policies. Each year of the contract is forecasted to cost around $451,523, illustrating a structured procurement plan focused on maintaining essential healthcare services through the availability of necessary radioactive materials. The proposal highlights the government's commitment to providing high-quality medical resources while ensuring compliance with regulatory standards.
    Similar Opportunities
    6505--NEW IDIQ - NON-PET Radiopharmaceuticals For Ordering periods from FY25 through FY29
    Buyer not available
    The Department of Veterans Affairs is preparing to issue a Request for Quote (RFQ) for NON-Positron Emission Tomography (PET) Radiopharmaceuticals intended for the VA Palo Alto Healthcare System. This procurement will cover ordering periods from Fiscal Year 2025 through Fiscal Year 2029 and is categorized under NAICS code 325412, emphasizing the importance of specialized radiopharmaceuticals in providing healthcare services to veteran patients. The RFQ is an open market solicitation aimed at awarding a single firm-fixed price contract, with solicitation documents expected to be available around February 14, 2025, and responses due by 12:00 PM Pacific Time on February 28, 2025. Interested parties can direct inquiries to Contracting Officer Edward Hunter at edward.hunter@va.gov or by phone at (702) 791-9000.
    6505--Radiopharmaceuticals Base Plus 4 Option Year IDIQ
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the procurement of radiopharmaceuticals, specifically Tc99m-derived products and related compounds, to be delivered to the Veterans Affairs Martinsburg Medical Center. The contract will commence on April 1, 2025, and includes a base year with four optional one-year extensions, concluding on March 31, 2030. These radiopharmaceuticals are critical for medical and diagnostic purposes within federal healthcare facilities, necessitating reliable delivery and compliance with strict safety and regulatory standards. Interested vendors must ensure they can meet the requirements for immediate orders, maintain quality control, and adhere to health regulations, with inquiries due by February 21, 2025, and responses by February 28, 2025. For further information, contact Contracting Officer Kami Hom at Kami.Hom@va.gov or by phone at 410-642-2411 x22404.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the supply of radiopharmaceuticals to the Naval Medical Center Portsmouth. The procurement aims to secure a range of unit dose radiopharmaceuticals essential for cancer patient care, including isotopes such as Tc-99m, I-123, and F-18, with specific quantities and pricing outlined for various medical applications over multiple contract periods from 2026 to 2030. These radiopharmaceuticals play a critical role in diagnostic imaging and treatment, ensuring that healthcare providers have access to necessary medical supplies for effective patient care. Proposals are due by March 11, 2025, with inquiries accepted until February 17, 2025; interested vendors should contact Carol Uebelacker at carol.e.uebelacker.civ@health.mil or call 210-952-8111 for further details.
    6505--Ga68 NETSPOT Radiopharmaceuticals Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of NETSPOT Ga68 radiopharmaceuticals for the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, PA. This procurement involves a firm-fixed-price contract for a 12-month period, commencing on June 4, 2025, and concluding on June 3, 2026, with a focus on supplying essential radiopharmaceuticals for imaging neuroendocrine tumors in adult patients. The selected vendor must be licensed by the Nuclear Regulatory Commission and adhere to strict delivery and regulatory standards, ensuring timely and compliant service. Interested vendors must submit their proposals by 10:00 AM EST on February 27, 2025, and can direct inquiries to Contract Specialist Christa Stine at christa.stine@va.gov or by phone at 570-824-3521.
    Q527--Y90 TheraSpheres OY3
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Special Notice for a sole source procurement of Y90 TheraSpheres from Boston Scientific Corporation, aimed at extending an existing contract for an additional two years. This procurement involves the delivery of various calibrated doses of TheraSpheres, which are critical for specific medical treatments within the Veterans Health Administration (VHA). Interested parties are invited to express their interest and capabilities by February 28, 2025, although this notice does not constitute a request for competitive quotations; the decision for competitive procurement will depend on the responses received. For further inquiries, interested vendors should contact Contract Specialist Mariangie Rios Vazquez at mariangie.riosvazquez@va.gov or by phone at 210-996-8816.
    F108--Pharmaceutical Waste Removal | MA (VA-25-00001921)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on pharmaceutical waste removal services at the Marion VA Medical Center and Evansville Health Care Center. The contract, valued at an estimated $47 million, is set aside exclusively for service-disabled veteran-owned small businesses and will encompass the collection and disposal of hazardous, non-hazardous, chemical, universal, and DEA drug waste, adhering to all relevant federal, state, and local regulations. This initiative underscores the importance of safe and compliant waste management practices within VA facilities, ensuring public safety and environmental protection. Interested vendors must submit their pricing and demonstrate the necessary qualifications by contacting Contract Specialist Lisa A Buchanan at Lisa.Buchanan1@va.gov, with the contract expected to commence in 2025.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bevacizumab injections, a critical pharmaceutical product used in various healthcare settings for veterans. Vendors are required to meet specific criteria, including providing unique National Drug Codes (NDC) and adhering to the Drug Supply Chain Security Act regulations, as the contract aims to ensure a reliable supply of this medication across government health care facilities. The selected contractor will be responsible for multiple line items of different Bevacizumab formulations, maintaining compliance with FDA manufacturing practices, and submitting quarterly sales reports, including cost recovery fees. Interested vendors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details, with submissions due by the specified deadlines outlined in the solicitation document.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire high-tech medical imaging equipment, specifically targeting the needs of the National Acquisition Center (NAC) for various healthcare facilities serving veterans. The procurement process is crucial for enhancing healthcare services, ensuring that the VA can provide state-of-the-art diagnostic and treatment capabilities. Key deadlines include the submission of vendor questions by February 19, 2025, and the final offer submission due by April 9, 2025. Interested vendors should direct inquiries to Contract Specialist Hermann A. Degbegni at hermann.degbegni@va.gov for further details.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    Q522 - Teleradiology Services for Oklahoma City VA Health Care System (OKCVAHCS)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for Teleradiology Services to support the Oklahoma City VA Health Care System (OKCVAHCS). The contract, estimated at $19 million, requires the contractor to provide off-site radiological interpretations, ensuring compliance with standards set by the American College of Radiology, and to maintain timely communication regarding abnormal findings. This procurement is critical for enhancing healthcare delivery to veterans by providing efficient access to radiology expertise, particularly during off-hours. Interested parties should contact Fanta M Cooper-Wells at fanta.cooper-wells@va.gov, with the performance period scheduled from March 1, 2025, to February 28, 2026, and options for extension available.